Beachbody Company, Inc. (BODI) Stock Forecast Oct. 20, 2026
Analysis updated on Oct. 20, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Beachbody Company, Inc. (BODI) stock forecast summary
On Oct. 20, 2026, BODI is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
Beachbody Company, Inc. is a small-cap company with a market capitalization of $31M.
For BODI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 38.0%, measured on 358 forecast dates between 2022-08-02 and 2026-07-22 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 21.0%, measured on 400 forecast dates between 2022-08-02 and 2026-09-18. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.3%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-22 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BODI included.
Follow BODI freeBODI price chart and AI forecast
How BODI ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Beachbody Company, Inc. (BODI) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Retail-Nonstore Retailers peers listed below that report each metric.
Valuation & Market
| Metric | BODI | Rank |
|---|---|---|
| Market Cap | $31M | – |
| P/E Ratio | 7.94x | – |
| P/B Ratio | 0.83x | – |
| EPS | $0.55 | – |
| Book Value/Share | $5.25 | – |
| Revenue/Share | $30.94 | – |
| FCF/Share | $1.07 | – |
Profitability & Margins
| Metric | BODI | Rank |
|---|---|---|
| ROIC | 28.2% | – |
| Gross Margin | 73.3% | – |
| Operating Margin | 8.2% | – |
| EBT Margin | 5.7% | – |
| Tax Rate | 1.0% | – |
Financial Health
| Metric | BODI | Rank |
|---|---|---|
| Current Ratio | 0.79x | – |
| Quick Ratio | 0.61x | – |
| D/E Ratio | 2.67x | – |
| Financial Leverage | 3.67x | – |
| Interest Coverage | 1.6x | – |
| Working Capital | -$16M | – |
Cash Flow
| Metric | BODI | Rank |
|---|---|---|
| Operating Cash Flow | $11M | 1/5 |
| Free Cash Flow | $8M | – |
| Capital Spending | -$3M | – |
| OCF Growth YoY | 1067.0% | – |
| FCF/Sales | 3.5% | – |
| CapEx/Sales | 1.5% | – |
Operational Efficiency
| Metric | BODI | Rank |
|---|---|---|
| Asset Turnover | 1.61x | – |
| Receivables Turnover | 162.9x | – |
| Inventory Turnover | 4.7x | – |
| Fixed Assets Turnover | 37.7x | – |
| Days Sales Outstanding | 2 days | – |
| Days Inventory | 78 days | – |
| Payables Period | 43 days | – |
| Cash Conversion Cycle | 38 days | – |
Income Statement
| Metric | BODI | Rank |
|---|---|---|
| Total Revenue | $219M | – |
| Operating Income | $18M | – |
| SG&A Expense | $112M | – |
| Cost of Goods Sold | $59M | – |
Dividend & Shareholder Information
| Metric | BODI | Rank |
|---|---|---|
| Shares Outstanding | 7M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $57M | 42.1% of assets |
| Cash & Short-term Investments | $32M | 23.7% of assets |
| Accounts Receivable | $1M | 1.0% of assets |
| Inventory | $13M | 9.2% of assets |
| Total Liabilities | $99M | 72.8% of assets |
| Short-term Debt | $66M | 48.5% of assets |
BODI quarterly financials and insider trading
Beachbody Company, Inc. (BODI) industry peers
Companies classified under the same SEC industry code as Beachbody Company, Inc. (Retail-Nonstore Retailers): 5 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere BODI sits on the market map
Beachbody Company, Inc. (BODI) stock news
Loading...
Beachbody Company, Inc. (BODI) stock forecast FAQ
What is the Beachbody Company, Inc. (BODI) stock forecast?
On Oct. 20, 2026, BODI is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
How accurate are Beachbody Company, Inc. stock predictions?
For BODI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 38.0%, measured on 358 forecast dates between 2022-08-02 and 2026-07-22 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 21.0%, measured on 400 forecast dates between 2022-08-02 and 2026-09-18. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Beachbody Company, Inc. forecasts updated?
Beachbody Company, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 20, 2026.
Which companies are Beachbody Company, Inc.'s industry peers?
5 issuers in our coverage, BODI included, share the SEC industry code Retail-Nonstore Retailers. The largest are: Global Ai, Inc. (GLAI), Natural Resource Holdings, Inc. (NRHI), Kaival Brands Innovations Group, Inc. (KAVL), Global Warming Solutions, Inc. (GWSO).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.